NEWSROOM
SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America
SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador Fort Lauderdale, FL., September 3, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery...
SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock
Fort Lauderdale, FL., August 30, 2024 - PRISM MediaWire - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update to its shareholders and the investment community on the status of its audit process and the trading market for its common stock. As previously reported in its Securities and Exchange...
AmpliTech Group’s Bookings Surpass $1M In August 2024
In Addition To Above Bookings, Spectrum Semiconductor Materials Division Completes $700K Single Sale Transaction During The Week of August 26th 2024 Hauppauge, NY, August 30, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and...
A New Era of Growth and Innovation at JP3E – A Message from the New CEO
NEW YORK, Aug. 30, 2024 - PRISM MediaWire -JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc. Dear JP3E Shareholders, I am both honored and excited to introduce myself as the new CEO of JP 3E Holdings. As we embark on this pivotal moment in our company's history, I am eager to share the vision and strategic direction to guide us into a future brimming with potential and opportunity. At JP3E, we are at the intersection of cutting-edge technologies and expanding market opportunities. Our...
Shorepower Technologies Wins Phase 1 Contract with US Department of Energy
Eligible to Apply for Phases 2 and 3, valued at $650k PORTLAND, August 30, 2024 - In June 2024, the U.S. Department of Energy (DOE) announced the 20 teams from 13 states who won Phase 1: Identify! for the Hero Re-X Before Recycling Prize challenge. Shorepower Technologies Inc. (OTC: SPEV) is pleased to announce they are among this winning cohort and now qualify to participate in Phases 2 and 3, which could yield additional awards of up to $650,000 - to demonstrate and develop an innovative...
Premier Graphene’s Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests
Imperial Valley, California, August 29, 2024 – Premier Graphene Inc. (OTC: BIEI), formerly Premier Biomedical Inc., announced today a groundbreaking technical report with significant implications for the road and highway construction industries. Building on our successful integration of our high-grade, efficacious graphene in cement, the testing conducted by Baja California Test S.A. de R.L. de C.V., highlights that the integration of graphene into asphalt mixtures, demonstrates again...
BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, will present at the H.C. Wainwright 26th Annual Global Investment Conference held on September 9th through 11th in New York City at the Lotte Palace Hotel....
BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025
BranchOut Food estimated to finish year at $8 million in Net Revenue Net Revenue for 1st half 2024 up over 640% from revenue in 1st half 2023 The Company estimates $5 million in Revenue for 2nd half of 2024, double that of the same period last year, to finish 2024 near $8 million Opening new production facility in Peru with about $40 mm in capacity with first production anticipated in October Completed combined financing of $5.4 million in June and July 2024 to finance completion of new...
BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io
Las Vegas, NV, August 27, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce that this week, the company will launch its first liquidity pool partnership on BLAQlp.io with the debut of the BLAQ token on both the Ethereum and ZEUS blockchains. The exact date and time for the launch will be announced with 24 hours prior notice, based on market conditions and other factors. As previously announced, the core smart contract powering BLAQlp.io allows funders to directly contribute to...
Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York
Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway Pittsburgh, PA, August 27, 2024 – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York City at the Lotte New York Palace Hotel on September 9 through 11, 2024. Admission to H.C. Wainwright’s conference is for qualified investors, and Lipella will be giving a virtual...